CytomX Therapeutics Inc (CTMX)
1.08
-0.01
(-0.92%)
USD |
NASDAQ |
Dec 23, 14:14
CytomX Therapeutics Profit Margin (Quarterly): 17.16% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Spero Therapeutics Inc | -219.3% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 7.63% |
| Operating Margin (Quarterly) | 12.30% |
| Return on Net Operating Assets | 64.47% |